This week in gene and cell therapy - 5 January 2018
Gene and cell therapy headlines 1 - 5 January
UK healthcare agency NICE approves Strimvelis for ADA-SCID
Price for Luxturna set at $425.000 per eye
Gene therapy restores normal blood glucose levels in mice with type 1 diabetes
CAR T cells may be able to help fight HIV